1. Home
  2. LSBK vs MNOV Comparison

LSBK vs MNOV Comparison

Compare LSBK & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSBK
  • MNOV
  • Stock Information
  • Founded
  • LSBK 1891
  • MNOV 2000
  • Country
  • LSBK United States
  • MNOV United States
  • Employees
  • LSBK N/A
  • MNOV N/A
  • Industry
  • LSBK Savings Institutions
  • MNOV Biotechnology: Pharmaceutical Preparations
  • Sector
  • LSBK Finance
  • MNOV Health Care
  • Exchange
  • LSBK Nasdaq
  • MNOV Nasdaq
  • Market Cap
  • LSBK 91.1M
  • MNOV 91.7M
  • IPO Year
  • LSBK 2006
  • MNOV 2005
  • Fundamental
  • Price
  • LSBK $15.80
  • MNOV $2.00
  • Analyst Decision
  • LSBK
  • MNOV Strong Buy
  • Analyst Count
  • LSBK 0
  • MNOV 1
  • Target Price
  • LSBK N/A
  • MNOV $9.00
  • AVG Volume (30 Days)
  • LSBK 3.4K
  • MNOV 17.9K
  • Earning Date
  • LSBK 01-24-2025
  • MNOV 02-18-2025
  • Dividend Yield
  • LSBK 3.38%
  • MNOV N/A
  • EPS Growth
  • LSBK 7.32
  • MNOV N/A
  • EPS
  • LSBK 0.88
  • MNOV N/A
  • Revenue
  • LSBK $25,846,000.00
  • MNOV N/A
  • Revenue This Year
  • LSBK N/A
  • MNOV N/A
  • Revenue Next Year
  • LSBK N/A
  • MNOV N/A
  • P/E Ratio
  • LSBK $17.98
  • MNOV N/A
  • Revenue Growth
  • LSBK N/A
  • MNOV N/A
  • 52 Week Low
  • LSBK $10.30
  • MNOV $1.12
  • 52 Week High
  • LSBK $16.56
  • MNOV $2.55
  • Technical
  • Relative Strength Index (RSI)
  • LSBK 71.76
  • MNOV 53.96
  • Support Level
  • LSBK $15.45
  • MNOV $1.82
  • Resistance Level
  • LSBK $15.78
  • MNOV $1.97
  • Average True Range (ATR)
  • LSBK 0.33
  • MNOV 0.07
  • MACD
  • LSBK 0.12
  • MNOV 0.00
  • Stochastic Oscillator
  • LSBK 100.00
  • MNOV 66.67

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

Share on Social Networks: